Results 101 to 110 of about 31,195 (193)
The presence of sub-minimal inhibitory concentration (sub-MIC) antibiotics in our environment is widespread, and their ability to induce antibiotic resistance is inevitable.
Cunwei Liu +4 more
core +1 more source
The emergence and widespread of tigecycline resistance undoubtedly poses a serious threat to public health globally. The exploration of combination therapies has become preferred antibacterial strategies to alleviate this global burden.
Feifei Sun +6 more
doaj +1 more source
Salvage Use of Tigecycline for Severely Ill Children
Objective: Tigecycline has a wide spectrum antimicrobial activity including multi-drug resistant and extended drug resistant nosocomial Gram-negative bacteria. Although its pediatric use has not been approved, clinicians are sometimes obligated to choose
Akturk, Hacer +9 more
core +1 more source
Cerebrospinal fluid penetration of tigecycline
Today very little is known about tigecycline penetration into cerebrospinal fluid (CSF). We report, in a clinical setting, tigecycline concentration, and the area under concentration-time curve (AUC) - both in blood and in CSF - of a patient affected by
Carlo Pallotto +6 more
core
Resistance to tigecycline increased in a stepwise manner (as a fold increase over the MIC of K. pneumoniae XH209) following serial passage in tigecycline.
Qiong Chen (327492) +8 more
core +1 more source
EUCAST Technical Note on tigecycline
Tigecycline is an injectable antibacterial agent derived from the tetracyclines and classified by the manufacturer as a glycylcycline. Tigecycline was registered by the European Medicines Agency (EMEA) in May 2006 for parenteral use in complicated ...
HRYNIEWICZ W. +10 more
core +1 more source
AdeABC-mediated efflux and tigecycline MICs for epidemic clones of Acinetobacter baumannii
Objectives Tigecycline non-susceptibility in individual Acinetobacter baumannii isolates has been associated with up-regulation of the resistance–nodulation–division (RND)-type efflux system, AdeABC.
Thomas, Claire P. +19 more
core +1 more source
Although tigecycline is considered one of the few therapeutic options for carbapenem-resistant Acinetobacter baumannii (CRAB) bacteraemia, its role in the treatment of CRAB bacteraemia remains unclear.
Kim, Eu Suk +9 more
core +1 more source
In Vitro Activity Of Tigecycline Against Brucella Spp.
Objectives: There are no published data regarding efficacy of tigecycline in brucellosis and in vitro data are scarce. We compared the in vitro activity of tigecycline to that of trimethoprim-sulfamethoxazole, rifampicin, tetracycline, streptomycin and ...
Gur, Deniz +2 more
core
Real‑World Evaluation of Omadacycline Switch Therapy for Multidrug‑Resistant Bacterial Pneumonia in Patients with Tigecycline Intolerance. [PDF]
Zhu Y, Liang L, Zhang J, Ju Y.
europepmc +1 more source

